Biotricity, Inc. (NASDAQ: BTCY) is a medical technology company specializing in the development and commercialization of remote monitoring solutions for chronic disease management. The company’s core focus is on capturing real-time physiological data to improve patient outcomes, reduce hospital readmissions and support value-based care models. Biotricity’s offerings are designed to bridge the gap between clinical environments and patients’ homes, enabling clinicians to make informed decisions based on continuous biometric feedback.
The company’s flagship product line includes wearable multi-channel ECG monitors, such as the Bioflux® integrated networked biosensor, and the Bioheart® rhythm monitoring service. These FDA-cleared and CE-marked devices transmit encrypted data via cellular or Bluetooth connections to Biotricity’s secure Bioportal® telemedicine platform, where proprietary algorithms analyze heart rate, rhythm abnormalities and other vital signs. In addition to cardiac monitoring, Biotricity has expanded its product suite to include remote respiratory monitoring and wellness solutions tailored to pre-operative, post-operative and chronic care populations.
Founded in Southern California, Biotricity has established a global footprint with headquarters in Newport Beach, California, and research and development facilities in Israel. The company’s remote diagnostics technology has been deployed across the United States and in select international markets, with strategic partnerships in telehealth and clinical research. Biotricity continues to explore cross-border collaborations aimed at integrating its platform into broader digital health ecosystems and value-based reimbursement frameworks.
Biotricity is led by CEO Oded Shraga, whose experience in medical device development and digital health innovation drives the company’s strategic vision. The executive team combines expertise in healthcare technology, regulatory affairs and clinical operations to support ongoing product enhancements, regulatory submissions and market expansion efforts. Through its integrated hardware-software approach, Biotricity aims to set a new standard for remote patient monitoring and telemedicine-enabled care delivery.
AI Generated. May Contain Errors.
Free BTCY Stock Alerts